Richard Culbert Fcca Email & Phone Number

West Chester, Pennsylvania, United States

London, Greater London, GB

• Senior Corporate Finance Executive driving significant gains in market share, cost savings, revenue, and growth through expertise. Develop and execute global corporate financial strategy to optimize operational.
• Advised on pre-Pandemic vaccines offering, pricing, strategic positioning, target marketsThird Bridge, London, UK
• Advised on right-sizing R&D investment and associated R&D finance function in the vaccines research and manufacturing sector
• Categorized R&D spend, areas of opportunity, pre-pandemic contracting, and target markets CORE COMPETENCIES
• Accounting
• Business Planning

92866 Issy Les Moulineaux Cedex 9, FR

• Finance lead for 6 Integrated Facilities Management contracts totaling $200+M of revenue in the North American Life Sciences market
• Led a team of 21 located across the US supporting pharmaceutical manufacturing, R&D and commercial offices at 30+ client sites located in the US, Canada and Puerto Rico
• Finance partner to the SVP IFM Life Sciences, including advising on investment decisions, contract negotiations, client conflict resolution and review of contractual terms and obligations

Blue Bell, Pennsylvania, US

• Managed a team of 24 based across the US, UK, Australia, India, and Brazil and mentored two interns
• Led the FP&A team through the quarter end close process including preparation of shareholder and main board briefing decks during a time of uncertainty and change
• Active member of the Unisys Disclosure Committee for investor communications and SEC 10Q submission
• Drove the 5 year strategic planning process, including collaborating with the regional finance heads and the corporate strategy team to the delivery of a strategic plan that met the corporation’s long term goals
• Developed a set of KPI's for the overall Unisys finance function, working collaboratively with the CFO and other finance leaders to achieve consensus on a set of realistic KPIs for finance

Melbourne, Victoria, AU

• Hired a team of 11 based across the US, UK, Italy, Australia, and Argentina for a multinational influenza vaccine / pre pandemic vaccine manufacturer and distributor
• Led finance stream of the 5 year strategic revenue plan, collaborating effectively with the relevant regional commercial heads and brand strategy teams to develop a plan that delivered 40% growth on key brands with.
• Oversaw all aspects of monthly reporting, budgeting and forecasting for a $1BN revenue commercial operation
• Drove standardization of payments terms to reduce average payment days from 90+ to average 60 days
• Optimized the Right of Return (RoR) cycle to streamline the process, reduce the risk of returns, and improve RoR provision accuracy for the US business
• Implemented effective monthly reporting and analysis to improve visibility of key drivers in terms of volume and price variances to target for the seasonal influenza business

Brentford, Middlesex, GB

• Controlled $910M operating budget divided across 3 global support organizations (24 facilities, 1200 FTEs) overseeing worldwide real estate and facilities, legal, and compliance
• Led a team of 12 finance directors and managers engaged in budgeting, forecasting, capital planning, and decision support·
• Drove $160M in annual facilities cost savings by leading a 3-year site reduction program effective in reducing the facilities footprint 15%
• Designed a space and occupancy billing model that incentivized businesses to give up unneeded or underutilized facilities space resulting in a consolidation of facilities where feasible, along with the closing and.
• Spearheaded the finance lead of a facilities outsourcing initiative that replaced 43 subcontractors and 500+ in-house staff with 3 global outsourced services contracts valued at $1.6B, producing a $40M savings over 3.
• Won business approval for a new $75M corporate headquarters in Singapore, effectively conveying to the CFO and Treasury Head the nuances associated with lease vs. buy transactions in Singapore vs traditional US model

Brentford, Middlesex, GB

• Directed a team of 31 located across the US and UK
• Charged with all accounting activities in support of GSK’s global research and development operations, a $400M footprint comprising of 28 sites and 15K FTEs extending across 3 continents

Brentford, Middlesex, GB

• Directed a team of 65 through 5 direct reports as De facto CFO for the GSK corporate business ($1.9B+, 1,500 FTEs, 55 entities in the U.S. and U.K.), reporting to the SVP Group Financial Controller

Brentford, Middlesex, GB

• Promoted to Director of U.S. Corporate Management Accounting in 2001, taking over budgeting, forecasting, and actuals reporting for U.S. corporate operations and assuring delivery of aggressive post-merger synergy.
• Cut $9M in operational expense
• Shaved 2 days off the External Legal Fee reporting effort
• Improved tracking of IP litigation spend
• Deployed Hyperion ERP

Brentford, Middlesex, GB

• Joined the Corporate Accounts Department (CAD) as Finance Manager of Accounting Services when Glaxo Wellcome ranked as the world’s 3rd-largest pharmaceutical company by revenues.
• Lead a UK-based team of 23
• Developed the company’s first web-based expense claim system
• Charted the CAD’s Y2K contingency plan
• Co-led a joint initiative with SmithKline Beecham to integrate accounting services functions following the companies’ merger announcementEARLY EXPERIENCE:
• Began career with BBHW Chartered Accountants in London before moving into the retail sector at the corporate offices of Selfridges plc.

Bachelor Of Science (Bs), Biology

Fcca, Accountancy And Finance